In a case that continues to polarize America and the world nearly 18 months later, Luigi Mangione, 27, stands accused of the December 4, 2024, ᴀssᴀssination of Brian Thompson, CEO of UnitedHealthcare. The cold-blooded shooting outside a Midtown Manhattan H๏τel sparked immediate outrage—and unexpected celebration—exposing deep fury over America’s broken healthcare system.

Thompson, 50, was gunned down with a 3D-printed firearm as he walked to a conference. Mangione, an Ivy League-educated former tech worker with chronic back pain, was arrested five days later in Altoona, Pennsylvania, carrying a fake ID, a silencer, and a handwritten manifesto. Prosecutors cite diary entries: “The target is insurance. It checks every box.”

The public reaction stunned observers. While many condemned the murder, social media erupted with support. Graffiti reading “Luigi Mangione, hero of the people” appeared from New York to Marseille. Hashtags like #DenyDefendDepose trended globally, referencing the insurance industry’s alleged tactics. Supporters hailed Mangione as a modern Robin Hood striking back at “Big Pharma” profits amid rising premiums and claim denials.

Critics, however, label him a dangerous vigilante whose actions inspired copycat threats and violence. Federal prosecutors initially sought the death penalty; a judge ruled it out in 2026. Mangione’s state trial is now set for September 2026, with the federal case pushed to January 2027.

As the debate rages, the case has forced a national reckoning on healthcare. Whether Mangione is remembered as folk hero or cold-blooded killer may depend on the verdict—and on whether systemic reform follows the shock of his alleged act.